Advertisement

Topics

FDA Approves First Drug for GVHD After Stem Cell Transplant

08:49 EDT 2 Aug 2017 | Medscape

For the first time, the agency has approved a drug for treatment of chronic graft-vs-host disease after hematopoietic stem cell transplant.
FDA Approvals

Original Article: FDA Approves First Drug for GVHD After Stem Cell Transplant

NEXT ARTICLE

More From BioPortfolio on "FDA Approves First Drug for GVHD After Stem Cell Transplant"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...